KENNEDY CAPITAL MANAGEMENT LLC

Position in HROW — Harrow, Inc.

CIK 884589 ST LOUIS, MO

Position in HROW

as of Mar 31, 2026 · filed May 13, 2026 Compact

Position Value

$2,618,266

-$675,955 QoQ

Shares Held

74,256

+10.5% QoQ

Ownership

0.199%

of shares outstanding

% of Portfolio

0.06%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2023

11 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

KENNEDY CAPITAL MANAGEMENT LLC holds $41,938,404 across 7 Drug Manufacturers - Specialty & Generic names. HROW ranks #4 (6.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ANIP	Ani Pharmaceuticals Inc	293,996	$22,608,292
2	NBIX	Neurocrine Biosciences Inc	55,055	$7,252,945
3	XERS	Xeris Biopharma Holdings, Inc.	1,240,692	$7,196,013
4	HROW	Harrow, Inc. This page	74,256	$2,618,266
5	ZTS	Zoetis Inc.	8,496	$1,004,312
6	AMRX	Amneal Pharmaceuticals, Inc.	50,977	$633,644
7	VTRS	Viatris Inc	46,257	$624,932

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$2,618,266	74,256	+10.5%	Shares	Sole	2026-05-13
2025-12-31	$3,294,221	67,229	-0.6%	Shares	Sole	2026-02-13
2025-09-30	$3,259,136	67,645	-0.4%	Shares	Sole	2025-11-13
2025-06-30	$2,073,910	67,908	+7.8%	Shares	Sole	2025-08-13
2025-03-31	$1,676,411	63,023	-0.6%	Shares	Sole	2025-05-13
2024-12-31	$2,126,902	63,395	-39.2%	Shares	Sole	2025-02-13
2024-09-30	$4,687,664	104,263	-1.3%	Shares	Sole	2024-11-14
2024-06-30	$2,207,550	105,675	-11.2%	Shares	Sole	2024-08-14
2024-03-31	$1,574,713	119,026	-0.5%	Shares	Sole	2024-05-15
2023-12-31	$1,340,304	119,670	-1.8%	Shares	Sole	2024-02-14
2023-09-30	$1,750,380	121,808	—	Shares	Sole	2023-11-14
No filing history on record for this holder in this stock.